¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023 ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ (ICBMT 2023) - 9¿ù 1ÀÏ (2ÀÏÂ÷) : 2023-09-01

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023 ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ (ICBMT 2023) - 9¿ù 1ÀÏ (2ÀÏÂ÷) : 2023-09-01
±³À°ÀÏÀÚ : 2023-09-01
±³À°Àå¼Ò : º¤½ºÄÚ

±³À°ÁÖÁ¦ : 2023 ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ (ICBMT 2023) - 9¿ù 1ÀÏ (2ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ
´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581  

À̸ÞÀÏ : bmt@kams.or.kr

±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú

Âü¼®¿¹»óÀÎ : 500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 7 ½Ã°£ 40ºÐ

¼¼ºÎ¼ö°­·á : 150,000¿ø  

ºñ°í Àü°øÀÇ/°£È£»ç/¿¬±¸¿ø ¹× ±âŸ 80,000¿ø, Çлý 50,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 09¿ù 01ÀÏ Auditorium 09:30~10:10 Mesenchymal Stem Cell Therapy Katarina LeBlanc(Karolinska Institutet)

±³À°½Ã°£ 09¿ù 01ÀÏ Auditorium 10:10~10:50 NK-Cell Based Therapies Dan Kaufman(University of California San Diego)

±³À°½Ã°£ 09¿ù 01ÀÏ Auditorium 11:00~11:40 How to Improve the Outcome of CBT Vanderson Geraldo Rocha(Universidade de Sao Paulo)

±³À°½Ã°£ 09¿ù 01ÀÏ Auditorium 11:40~12:20 Trends and Future of the HSCT Using Mismatched Donors Anna Sureda(Blood Cell Barcelona Hematology Institute)

±³À°½Ã°£ 09¿ù 01ÀÏ Room A 12:30~13:10 How do I avoid Complication of Chronic GVHD? Bipin Savani(Vanderbilt University Medical Center)

±³À°½Ã°£ 09¿ù 01ÀÏ Room A 13:20~13:50 Cell Therapy Hyunsoo Cho(Yonsei University College of Medicine)

±³À°½Ã°£ 09¿ù 01ÀÏ Room A 13:50~14:20 Pediatrics Perspective Rayne Rouce(Baylor College of Medicine)

±³À°½Ã°£ 09¿ù 01ÀÏ Room A 14:20~14:50 Stem Cell Transplant Julie Vose(University of Nebraska Medical Center)

±³À°½Ã°£ 09¿ù 01ÀÏ Room A 15:00~16:00 Correlation between clinical diagnosis and histopathological findings of liver dysfunction after allogeneic-HSCT Kim Ka Young( The Catholic University of Korea, Seoul)

±³À°½Ã°£ 09¿ù 01ÀÏ Poster Zone 3F 16:10~16:30 Effectiveness of 2nd Line Autologous Peripheral Blood Stem Cell in Diffuse Large B-Cell Lymphoma Patients in the Era of CAR-T Therapy Jeon Youngwoo( The Catholic University of Korea, Seoul)

±³À°½Ã°£ 09¿ù 01ÀÏ Room A 16:40~17:10 Cellular Therapies in Multiple Myeloma: Revolutionizing Treatment Approaches Ahmet Kursat Gunes(Ankara City Hospital)

±³À°½Ã°£ 09¿ù 01ÀÏ Room D 17:10~17:40 Dose Intensity for Conditioning in Allogeneic Hematopoietic Cell Transplantation: Reduced Intensity Conditioning Versus. Myeloablative Conditioning Yunsuk Choi(University of Ulsan College of Medicine)

±³À°½Ã°£ 09¿ù 01ÀÏ Room D 17:40~18:10 Novel Conditioning Regimens for Hematopoietic Cell Transplantation Sung Nam Lim(Inje University College of Medicine)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023 ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ (ICBMT 2023) - 9¿ù 1ÀÏ (2ÀÏÂ÷) : 2023-09-01""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2023³â ¼­¿ï¾Æ»êº´¿ø ¾Ï ½ÉÆ÷Áö¾ö : 2023-09-01
´ÙÀ½±Û 2023³â ´ëÇÑÁ¤½Å¾à¹°ÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2023-09-01
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21122 ¼­¿ï Çѱ¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ 2024 KSCRS Annual Symposium(2ÀÏÂ÷) : 2024-07-14 0 62 2024-06-19
21121 ¼­¿ï Á¦8ȸ ÀüÀÓÀÇ Àü°øÀÇ °³¿øÀǸ¦ À§ÇÑ °£Áúȯ ¿¬¼ö°­Á : 2024-07-14 0 85 2024-06-19
21120 ¼­¿ï 24³âµµ ´ëÇѱâ´ÉÀÇÇÐȸ Çϰ迬¼ö°­Á : 2024-07-14 0 44 2024-06-19
21119 ¼­¿ï ´ëÇÑÇ÷°üÇÐȸ KOVAS 2024 Summer Conference (2ÀÏÂ÷) : 2024-07-13 0 57 2024-06-19
21118 ÀüºÏ 2024³â ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ Çϰ迬¼ö±³À° : 2024-07-13 0 58 2024-06-19
21117 ¼­¿ï ´ëÇÑÁ·ºÎÁ·°üÀýÇÐȸ - Á¦1ȸ ´ç´¢¹ß ½ÉÆ÷Áö¾ö : 2024-07-13 0 28 2024-06-19
21116 ¼­¿ï õ½Ä¿¬±¸È¸ Workshop 2024 : 2024-07-13 0 30 2024-06-19
21115 ¼­¿ï 2024 Àç°ü·ùÄ¡·á¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¿ò ¹× ÃÑȸ : 2024-07-13 0 59 2024-06-19
21114 ¼­¿ï Çѱ¹¹é³»Àå±¼Àý¼ö¼úÇÐȸ 2024 KSCRS Annual Symposium(1ÀÏÂ÷) : 2024-07-13 0 49 2024-06-19
21113 ¼­¿ï 2024 ´ç´¢º´½ÅÁõ ½ÉÆ÷Áö¾ö : 2024-07-13 0 22 2024-06-19
21112 ¼­¿ï ´ëÇÑÇ÷°üÇÐȸ KOVAS 2024 Summer Conference (1ÀÏÂ÷) : 2024-07-12 0 22 2024-06-19
21111 ¼­¿ï 2024 ´ëÇѽÅÃéÀåÀ̽Ŀܰú¿¬±¸È¸ ÇÏ°è Çмú´ëȸ : 2024-07-12 0 28 2024-06-19
21110 ¼­¿ï ´ëÇÑ¿ì¿ïÁ¶¿ïº´ÇÐȸ Çϰ迬¼ö±³À° : 2024-07-12 0 49 2024-06-19
21109 ¼­¿ï (¿Â¶óÀÎ) ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ – Á¦5Â÷ Àå¾ÖÆÇÁ¤ ¿Â¶óÀÎ ½ÉÆ÷Áö¾ö : 2024-07-07 0 18 2024-06-19
21108 ¼­¿ï 2024³â ´ëÇѺñ´¢ºÎÀΰúÇÐȸ Á¦27Â÷ Çмú´ëȸ (¿ÀÇÁ¶óÀÎ) : 2024-07-07 0 50 2024-06-19
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷